302 related articles for article (PubMed ID: 25911380)
41. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation.
Li L; Soetandyo N; Wang Q; Ye Y
Biochim Biophys Acta; 2009 Feb; 1793(2):346-53. PubMed ID: 18952128
[TBL] [Abstract][Full Text] [Related]
42. The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1.
Shembade N; Pujari R; Harhaj NS; Abbott DW; Harhaj EW
Nat Immunol; 2011 Jul; 12(9):834-43. PubMed ID: 21765415
[TBL] [Abstract][Full Text] [Related]
43. Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling.
Li L; Hailey DW; Soetandyo N; Li W; Lippincott-Schwartz J; Shu HB; Ye Y
Biochim Biophys Acta; 2008 Jun; 1783(6):1140-9. PubMed ID: 18329387
[TBL] [Abstract][Full Text] [Related]
44. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases.
De Valck D; Jin DY; Heyninck K; Van de Craen M; Contreras R; Fiers W; Jeang KT; Beyaert R
Oncogene; 1999 Jul; 18(29):4182-90. PubMed ID: 10435631
[TBL] [Abstract][Full Text] [Related]
45. A20 inhibits NF-kappaB activation independently of binding to 14-3-3 proteins.
De Valck D; Heyninck K; Van Criekinge W; Vandenabeele P; Fiers W; Beyaert R
Biochem Biophys Res Commun; 1997 Sep; 238(2):590-4. PubMed ID: 9299557
[TBL] [Abstract][Full Text] [Related]
46. Direct, noncatalytic mechanism of IKK inhibition by A20.
Skaug B; Chen J; Du F; He J; Ma A; Chen ZJ
Mol Cell; 2011 Nov; 44(4):559-71. PubMed ID: 22099304
[TBL] [Abstract][Full Text] [Related]
47. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
48. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
49. A20 promotes Brucella intracellular growth via inhibition of macrophage cell death and activation.
Wei P; Cui G; Lu Q; Yang L; Guan Z; Sun W; Zhao Y; Wang S; Peng Q
Vet Microbiol; 2015 Jan; 175(1):50-7. PubMed ID: 25433453
[TBL] [Abstract][Full Text] [Related]
50. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.
Evans PC; Ovaa H; Hamon M; Kilshaw PJ; Hamm S; Bauer S; Ploegh HL; Smith TS
Biochem J; 2004 Mar; 378(Pt 3):727-34. PubMed ID: 14748687
[TBL] [Abstract][Full Text] [Related]
51. Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain.
Pranski EL; Van Sanford CD; Dalal NV; Orr AL; Karmali D; Cooper DS; Costa N; Heilman CJ; Gearing M; Lah JJ; Levey AI; Betarbet RS
Neurosci Lett; 2012 Jun; 520(1):104-9. PubMed ID: 22634524
[TBL] [Abstract][Full Text] [Related]
52. [Protective effect of cotransfection of A20 and HO-1 gene against the apoptosis induced by TNF-α in rat islets in vitro].
Lu Z; Shen SX; Zhi DJ; Xu H; Guo LH; Luo FH
Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):420-5. PubMed ID: 24120058
[TBL] [Abstract][Full Text] [Related]
53. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements.
Krikos A; Laherty CD; Dixit VM
J Biol Chem; 1992 Sep; 267(25):17971-6. PubMed ID: 1381359
[TBL] [Abstract][Full Text] [Related]
55. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6.
Heyninck K; Beyaert R
FEBS Lett; 1999 Jan; 442(2-3):147-50. PubMed ID: 9928991
[TBL] [Abstract][Full Text] [Related]
56. Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain.
Bohgaki M; Tsukiyama T; Nakajima A; Maruyama S; Watanabe M; Koike T; Hatakeyama S
Biochim Biophys Acta; 2008 May; 1783(5):826-37. PubMed ID: 18029035
[TBL] [Abstract][Full Text] [Related]
57. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
[TBL] [Abstract][Full Text] [Related]
58. A20 Inhibits β-Cell Apoptosis by Multiple Mechanisms and Predicts Residual β-Cell Function in Type 1 Diabetes.
Fukaya M; Brorsson CA; Meyerovich K; Catrysse L; Delaroche D; Vanzela EC; Ortis F; Beyaert R; Nielsen LB; Andersen ML; Mortensen HB; Pociot F; van Loo G; Størling J; Cardozo AK
Mol Endocrinol; 2016 Jan; 30(1):48-61. PubMed ID: 26652732
[TBL] [Abstract][Full Text] [Related]
59. TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20.
Das S; Pandey K; Kumar A; Sardar AH; Purkait B; Kumar M; Kumar S; Ravidas VN; Roy S; Singh D; Das P
Immunol Cell Biol; 2012 Jul; 90(6):640-54. PubMed ID: 21968712
[TBL] [Abstract][Full Text] [Related]
60. A20 is dynamically regulated in the heart and inhibits the hypertrophic response.
Cook SA; Novikov MS; Ahn Y; Matsui T; Rosenzweig A
Circulation; 2003 Aug; 108(6):664-7. PubMed ID: 12900338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]